Policy Evidence: Data-Driven Decision-Making for Policy Making
Moderator
Lisa B Feng, DrPH, Bristol Myers Squibb, Washington, DC, United States
Speakers
Josh Trent, MA, Leavitt Partners, Washington, DC, United States; Nirosha Lederer, PhD, AstraZeneca, Washington, DC, United States; Liz Fowler, JD, PhD, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Erin Trish, PhD, USC Schaeffer Institute for Public Policy & Government Service, United States
ISSUE: Healthcare systems around the world are experiencing unprecedented pressures, balancing budget and economic, capacity and infrastructure, and workforce pressures. Every decision made has downstream effects and tradeoffs on patient outcomes, short-term budgets, and/or longer term fiscal impact. The strategic use of real world data (RWD) and real world evidence (RWE) is essential for informed evidence-based policymaking. Industry and government collaboration is necessary to generate timely, credible evidence policy using RWD to improve health outcomes, enhance system sustainability, and benefit society.
OVERVIEW: This session will discuss the types of data policymakers are looking for, generating evidence targeting stakeholders who are contemplating policy change, and how policy evidence and complements traditional medical and HEOR studies, and the potential to advance the field of policy evidence.
Topic
Health Policy & Regulatory, Organizational Practices, Study Approaches